Difference between revisions of "LncRNAWiki:M"
| Line 357: | Line 357: | ||
|MNX1 antisense RNA 2 | |MNX1 antisense RNA 2 | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |''MAP3K20-AS1'' | ||
| + | |[[MAP3K20-AS1]] | ||
| + | |N/A | ||
| + | |MAP3K20 antisense RNA 1 | ||
| + | |_ | ||
| + | |- | ||
| + | |''MYOSLID'' | ||
| + | |[[MYOSLID]] | ||
| + | |N/A | ||
| + | |myocardin-induced smooth muscle lncRNA, inducer of differentiation | ||
| + | |_ | ||
|} | |} | ||
Latest revision as of 12:39, 29 June 2017
| Name | Transcript ID | Alias | Description | Disease | |||||
|---|---|---|---|---|---|---|---|---|---|
| MAFA-AS1 | MAFA-AS1 | "RP11-909N17.3, TCONSN/A00014882" | MAFA antisense RNA 1 | _ | |||||
| MAFG-AS1 | MAFG-AS1 | N/A | MAFG antisense RNA 1 (head to head) | _ | |||||
| MAFTRR | MAFTRR | linc-MAF-4 | MAF transcriptional regulator RNA | _ | |||||
| MAGEA8-AS1 | MAGEA8-AS1 | RP5-869M20.2 | MAGEA8 antisense RNA 1 (head to head) | _ | |||||
| MALAT1 | ENST00000534336.1 | "HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562" | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer | |||||
| MAPKAPK5-AS1 | MAPKAPK5-AS1 | FLJ39616 | MAPKAPK5 antisense RNA 1 | _ | |||||
| mascRNA | lnc-SCYL1-1:5 | Malat1 | mascRNA (MALAT1-associated small cytoplasmic RNA) | _ | |||||
| MCM3AP-AS1 | MCM3AP-AS1 | "FLJ10508, NCRNA00031" | MCM3AP antisense RNA 1 | _ | |||||
| MDC1-AS1 | MDC1-AS1 | MDC1-AS | MDC1 antisense RNA 1 | bladder cancer | |||||
| MEF2C-AS1 | MEF2C-AS1 | N/A | MEF2C antisense RNA 1 | _ | |||||
| MEG3 | NONHSAT039745 | "Gtl2, ENSG00000214548" | maternally expressed 3 (non-protein coding) | bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes | |||||
| MEG8 | ENST00000553584.1 | "Bsr, ""Imprinted RNA near Meg3/Gtl2"", Irm, LINC00024, ""long intergenic non-protein coding RNA 24"", NCRNA00024, ""non-protein coding RNA 24"", Rian, ""RNA Imprinted and Accumulated in Nucleus"", ENSG00000258399" | Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8 | Prader-Willi/Angelman syndrome | |||||
| MEG9 | ENST00000553584.1 | LINC00584 | maternally expressed 9 (non-protein coding) | _ | |||||
| MESTIT1 | MESTIT1 | "NCRNA00040, MEST-AS1" | "MEST intronic transcript 1, antisense RNA" | _ | |||||
| MGAT3-AS1 | MGAT3-AS1 | TapSAKI | MGAT3 antisense RNA 1 | acute kidney injury | |||||
| MHRT | MHRT | Myheart | myosin heavy chain-associated RNA transcript | heart pathological hypertrophy | |||||
| MIAT | lnc-CRYBA4-2:1 | "FLJ25967, gomafu, LINC00066, lncRNA-MIAT, ""long intergenic non-protein coding RNA 66"", NCRNA00066, ""non-protein coding RNA 66"", Rncr2" | myocardial infarction associated transcript (non-protein coding) | myocardial infarction | |||||
| MIF-AS1 | MIF-AS1 | LOC284889 | MIF antisense RNA 1 | malaria susceptibility | |||||
| MIMT1 | MIMT1 | "MIM1, NCRNA00067, LINC00067" | MER1 repeat containing imprinted transcript 1 (non-protein coding) | _ | |||||
| MINCR | ENST00000517411.1 | TCONSN/A00015189 | MYC-induced long noncoding RNA | Burkitt lymphoma | |||||
| MIR100HG | ENST00000531381.1 | "AGD1, lncRNA-N2" | mir-100-let-7a-2 cluster host gene | myeloid leukemia | |||||
| MIR137HG | MIR137HG | N/A | MIR137 host gene | schizophrenia | |||||
| MIR155HG | NONHSAT081499 | "BIC, NCRNA00172" | MIR155 host gene | chronic lymphocytic leukemia | |||||
| MIR17HG | MIR17HG | "FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048" | miR-17-92a-1 cluster host gene | lymphoma, syndromic developmental defect | |||||
| MIR181A2HG | MIR181A2HG | N/A | MIR181A2 host gene | _ | |||||
| MIR210HG | MIR210HG | N/A | MIR210 host gene | inflammatory renal epithelial injury | |||||
| MIR222HG | ENST00000602507.1 | Lnc-Ang362 | MIR222 host gene | Ang II-associated cardiovascular disease | |||||
| MIR22HG | ENST00000574306.1 | "MGC14376, DKFZp686O06159, LOC554202" | MIR22 host gene | _ | |||||
| MIR34AHG | MIR34AHG | N/A | MIR34A host gene | _ | |||||
| MIR4435-2HG | MIR4435-2HG | "LINC00978, AGD2, AK001796" | MIR4435-2 host gene | _ | |||||
| MIR503HG | ENST00000414769.1 | "MGC16121, H19X" | MIR503 host gene | choriocarcinoma | |||||
| MIR600HG | MIR600HG | "GL012, FLJ22161" | MIR600 host gene | _ | |||||
| MIR663AHG | MIR663AHG | RP3-410C9.1 | MIR663A host gene | _ | |||||
| MIR7-3HG | MIR7-3HG | "PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2" | MIR7-3 host gene | _ | |||||
| MIR99AHG | ENST00000602580.1 | MONC | mir-99a-let-7c cluster host gene | myeloid leukemia | |||||
| MIRLET7BHG | MIRLET7BHG | linc-Ppara | MIRLET7B host gene | asbestos exposure-related lung cancer | |||||
| MIRLET7DHG | MIRLET7DHG | N/A | MIRLET7D host gene | _ | |||||
| MKRN3-AS1 | MKRN3-AS1 | "FNZ127, NCRNA00009, ZNF127-AS" | MKRN3 antisense RNA 1 | Prader-Willi syndrome ;Angelman syndromes | |||||
| MLK7-AS1 | MLK7-AS1 | N/A | MLK7 antisense RNA 1 | _ | |||||
| MLLT4-AS1 | MLLT4-AS1 | "HGC6.4, dJ431P23.3" | MLLT4 antisense RNA 1 (head to head) | _ | |||||
| MORF4L2-AS1 | MORF4L2-AS1 | N/A | MORF4L2 antisense RNA 1 | _ | |||||
| MT-LIPCAR | MT-LIPCAR | "uc022bqs.1, LIPCAR" | mitochondrially encoded long non-coding cardiac associated RNA | heart failure | |||||
| MYCNOS | MYCNOS | "NCYM, N-CYM, MYCN-AS1" | MYCN opposite strand | neuroblastoma | |||||
| MYCNUT | ENST00000433810.1 | lncUSMycN | MYCN upstream transcript (non-protein coding) | neuroblastoma | |||||
| MAGI2-AS3 | MAGI2-AS3 | ENST00000414797 | MAGI2 antisense RNA 3 | early-onset preeclampsia | |||||
| MAPT-AS1 | MAPT-AS1 | N/A | MAPT antisense RNA 1 | Parkinson's Disease | |||||
| MDS2 | MDS2 | N/A | myelodysplastic syndrome 2 translocation associated | myelodysplastic syndrome | |||||
| MEF2C-AS2 | MEF2C-AS2 | CTC-467M3.1 | MEF2C antisense RNA 2 | B cell lymphoma | |||||
| MELTF-AS1 | MELTF-AS1 | MFI2-AS1 | MELTF antisense RNA 1 | osteosarcoma | |||||
| MHENCR | MHENCR | N/A | melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489 | Melanoma | |||||
| MIR200CHG | MIR200CHG | U47924.27 | MIR200C and MIR141 host gene | Melanoma tumorigenesis | |||||
| MIR2052HG | MIR2052HG | N/A | MIR2052 host gene | breast cancer | |||||
| MIR3936HG | MIR3936HG | LOC553103, SLC22A5-AS1 | MIR3936 host gene | nasopharyngeal carcinoma, gastric cancer | |||||
| MIR4422HG | MIR4422HG | RP11-101C11.1 | MIR4422 host gene | B cell lymphoma | |||||
| MIR4713HG | MIR4713HG | RP11-108K3.1 | MIR4713 host gene | Colorectal adenocarcinoma | |||||
| MMP2-AS1 | MMP2-AS1 | ENST00000569037 | MMP2 antisense RNA 1 | early-onset preeclampsia | |||||
| MNX1-AS1 | MNX1-AS1 | CCAT5, LOC645249 | MNX1 antisense RNA 1 (head to head) | Ovarian Cancer | |||||
| MNX1-AS2 | MNX1-AS2 | ENST00000429228 | MNX1 antisense RNA 2 | early-onset preeclampsia | MAP3K20-AS1 | MAP3K20-AS1 | N/A | MAP3K20 antisense RNA 1 | _ |
| MYOSLID | MYOSLID | N/A | myocardin-induced smooth muscle lncRNA, inducer of differentiation | _ |
